Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tahirovic

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Methods of Information in Medicine|February 7, 2015
An averaging technique for the P300 spatial distributionA Tahirovic, M Matteucci, L Mainardi
Expert Opinion on Therapeutic Patents|February 10, 2025
Small molecule and peptide CXCR4 antagonists. A patent review from 2019 to 2024Zafer Sahin, Yesim A Tahirovic, Jiafeng Geng, et al.
Medicinski Arhiv|February 4, 2011
Primary percutaneous coronary interventions network in Bosnia and Herzegovina--Sarajevo's proposalMehmed Kulic, Anes Sosevic, A Tahirovic, et al.
Expert Opinion on Investigational Drugs|October 30, 2016
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIVMichelle B Kim, Kyle E Giesler, Yesim A Tahirovic, et al.
Expert Opinion on Therapeutic Patents|December 20, 2019
Small molecule and peptide-based CXCR4 modulators as therapeutic agents. A patent review for the period from 2010 to 2018Yesim A Tahirovic, Sameshnee Pelly, Edgars Jecs, et al.
Nature Communications|January 20, 2019
Structural elements of a pH-sensitive inhibitor binding site in NMDA receptorsMichael C Regan, Zongjian Zhu, Hongjie Yuan, et al.
Elife|May 25, 2018
An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groupsRiley Perszyk, Brooke M Katzman, Hirofumi Kusumoto, et al.
ACS Chemical Neuroscience|February 13, 2023
Novel GluN2B-Selective NMDA Receptor Negative Allosteric Modulator Possesses Intrinsic Analgesic Properties and Enhances Analgesia of Morphine in a Rodent Tail Flick Pain ModelLynnea D Harris, Michael C Regan, Scott J Myers, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 8, 2021
A Glutamate <i>N</i>-Methyl-d-Aspartate (NMDA) Receptor Subunit 2B-Selective Inhibitor of NMDA Receptor Function with Enhanced Potency at Acidic pH and Oral Bioavailability for Clinical UseScott J Myers, Kamalesh P Ruppa, Lawrence J Wilson, et al.
Neuron|March 3, 2015
Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effectsHongjie Yuan, Scott J Myers, Gordon Wells, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Methods of Information in Medicine|February 7, 2015
An averaging technique for the P300 spatial distributionA Tahirovic, M Matteucci, L Mainardi
Expert Opinion on Therapeutic Patents|February 10, 2025
Small molecule and peptide CXCR4 antagonists. A patent review from 2019 to 2024Zafer Sahin, Yesim A Tahirovic, Jiafeng Geng, et al.
Medicinski Arhiv|February 4, 2011
Primary percutaneous coronary interventions network in Bosnia and Herzegovina--Sarajevo's proposalMehmed Kulic, Anes Sosevic, A Tahirovic, et al.
Expert Opinion on Investigational Drugs|October 30, 2016
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIVMichelle B Kim, Kyle E Giesler, Yesim A Tahirovic, et al.
Expert Opinion on Therapeutic Patents|December 20, 2019
Small molecule and peptide-based CXCR4 modulators as therapeutic agents. A patent review for the period from 2010 to 2018Yesim A Tahirovic, Sameshnee Pelly, Edgars Jecs, et al.
Nature Communications|January 20, 2019
Structural elements of a pH-sensitive inhibitor binding site in NMDA receptorsMichael C Regan, Zongjian Zhu, Hongjie Yuan, et al.
Elife|May 25, 2018
An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groupsRiley Perszyk, Brooke M Katzman, Hirofumi Kusumoto, et al.
ACS Chemical Neuroscience|February 13, 2023
Novel GluN2B-Selective NMDA Receptor Negative Allosteric Modulator Possesses Intrinsic Analgesic Properties and Enhances Analgesia of Morphine in a Rodent Tail Flick Pain ModelLynnea D Harris, Michael C Regan, Scott J Myers, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 8, 2021
A Glutamate <i>N</i>-Methyl-d-Aspartate (NMDA) Receptor Subunit 2B-Selective Inhibitor of NMDA Receptor Function with Enhanced Potency at Acidic pH and Oral Bioavailability for Clinical UseScott J Myers, Kamalesh P Ruppa, Lawrence J Wilson, et al.
Neuron|March 3, 2015
Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effectsHongjie Yuan, Scott J Myers, Gordon Wells, et al.
Pageof 2